Clinical Trials Browser

Phase 2 × Terminated × osimertinib × Clear all

NCT04908956 2024-06-28

STEREO

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT04438902 2023-02-21

Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03784599 2022-11-10

TRAEMOS

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung